vimarsana.com
Home
Live Updates
Bausch + Lomb Broadens Eye Products Lineup Via $1.75B Deal W
Bausch + Lomb Broadens Eye Products Lineup Via $1.75B Deal W
Bausch + Lomb Broadens Eye Products Lineup Via $1.75B Deal With Novartis
Dry eye disease drug Xiidra is the centerpiece of the Bausch + Lomb acquisition. The deal with Novartis also includes two experimental products, one for eye pain and the other a medical device for delivering medicines to the eye.
Related Keywords
Japan ,
Japanese ,
Brent Saunders ,
Novartis ,
Takeda Pharmaceutical ,
Lomb Chairman ,
Weight Loss ,
Obesity ,
Verweight ,
Diabetes ,
Massachusetts ,
Medical Devices ,
Startups ,
Healthcare Innovation ,
Medcity News ,
San Francisco ,
Life Sciences ,
Accelerator ,
Rock Health ,
Startup Advice ,
Startup Funding ,
Patient Monitoring System ,
Otion Sensors ,
Dc ,
Healthcare It ,
Washington ,
Foodborne Pathogens ,
Iagnostics Company ,
Iagnostic Platforms ,
Minimally Invasive Surgery ,
Aser Surgery ,
Cambridge ,
Dealflow ,
Hospitals ,
Wellpoint ,
Ealthways ,
Ealth And Wellness ,
Mployee Wellness Programs ,
Investing ,
Wellness ,
Medtronic ,
Hanghai Innovation Center ,
China ,
R D ,
Mdt ,
Minneapolis ,
Minnesota ,
Publics ,
Twin Cities ,
Ulcerative Colitis ,
Abbott Labs ,
Humira ,
Doctors ,
Pharmaceuticals ,
Skin Disorders ,
D Anderson Cancer Center ,
Cancer ,
Texas ,
Renal Denervation ,
St Jude Medical ,
Stj ,
Emr ,
Hr ,
Electronic Health Records ,
Electronic Medical Records ,
Certified Emr ,
Ehr ,
Advanced Cellular Technology ,
Amyotrophic Lateral Sclerosis ,
Embryonic Stem Cells ,
Geron Corporation ,
Lou Gehrigs Disease ,
Macular Degeneration ,
Regenerative Medicine ,
Spinal Cord Damage ,
Value Based Healthcare System ,
Obamacare ,
Ee For Service Model ,
California ,
Cleveland ,
Health Insurance ,
Insurance ,
Ohio ,
Pennsylvania ,
Politics ,
Cancer Treatment Options Library ,
Aetna ,
Pet ,
Aet ,
Health It ,
Phi ,
Philadelphia ,
Acquisitions ,
Bausch Amp Lomb ,
Biopharma Nl ,
Deals ,
Dry Eye Disease ,
Xiidra ,
,